CN102365087A - 改善认知功能和降低心率的方法 - Google Patents

改善认知功能和降低心率的方法 Download PDF

Info

Publication number
CN102365087A
CN102365087A CN2010800157224A CN201080015722A CN102365087A CN 102365087 A CN102365087 A CN 102365087A CN 2010800157224 A CN2010800157224 A CN 2010800157224A CN 201080015722 A CN201080015722 A CN 201080015722A CN 102365087 A CN102365087 A CN 102365087A
Authority
CN
China
Prior art keywords
dha
acid
less
tfa
still less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800157224A
Other languages
English (en)
Chinese (zh)
Inventor
K·尤科-毛罗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
Martek Biosciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Martek Biosciences Corp filed Critical Martek Biosciences Corp
Priority to CN201810349154.XA priority Critical patent/CN108324706A/zh
Publication of CN102365087A publication Critical patent/CN102365087A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
CN2010800157224A 2009-02-02 2010-02-02 改善认知功能和降低心率的方法 Pending CN102365087A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810349154.XA CN108324706A (zh) 2009-02-02 2010-02-02 改善认知功能和降低心率的方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14931009P 2009-02-02 2009-02-02
US61/149,310 2009-02-02
US18354809P 2009-06-02 2009-06-02
US61/183,548 2009-06-02
PCT/US2010/022952 WO2010088700A1 (en) 2009-02-02 2010-02-02 Methods for improving cognitive function and decreasing heart rate

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CN201810349154.XA Division CN108324706A (zh) 2009-02-02 2010-02-02 改善认知功能和降低心率的方法
CN201410152946.XA Division CN104042600A (zh) 2009-02-02 2010-02-02 改善认知功能和降低心率的方法

Publications (1)

Publication Number Publication Date
CN102365087A true CN102365087A (zh) 2012-02-29

Family

ID=42041547

Family Applications (3)

Application Number Title Priority Date Filing Date
CN2010800157224A Pending CN102365087A (zh) 2009-02-02 2010-02-02 改善认知功能和降低心率的方法
CN201810349154.XA Pending CN108324706A (zh) 2009-02-02 2010-02-02 改善认知功能和降低心率的方法
CN201410152946.XA Pending CN104042600A (zh) 2009-02-02 2010-02-02 改善认知功能和降低心率的方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN201810349154.XA Pending CN108324706A (zh) 2009-02-02 2010-02-02 改善认知功能和降低心率的方法
CN201410152946.XA Pending CN104042600A (zh) 2009-02-02 2010-02-02 改善认知功能和降低心率的方法

Country Status (8)

Country Link
US (2) US20100203123A1 (https=)
EP (2) EP2391361A1 (https=)
JP (5) JP2012516852A (https=)
CN (3) CN102365087A (https=)
AU (2) AU2016201382A1 (https=)
CA (1) CA2751275A1 (https=)
HK (1) HK1202243A1 (https=)
WO (1) WO2010088700A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8207363B2 (en) 2009-03-19 2012-06-26 Martek Biosciences Corporation Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
US20110177061A1 (en) * 2009-07-10 2011-07-21 Martek Biosciences Corporation Methods of treating and preventing neurological disorders using docosahexaenoic acid
CN103732223A (zh) * 2011-05-19 2014-04-16 加利福尼亚大学董事会 用于认知能力下降的医疗食品
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US20130084272A1 (en) * 2011-09-29 2013-04-04 Philippe Perrin Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols
CA2903599A1 (en) * 2013-03-15 2014-09-18 Genspera, Inc. Methods for making cancer compositions
KR102416853B1 (ko) 2013-12-20 2022-07-05 마라 리뉴어블즈 코퍼레이션 미생물로부터 오일을 회수하는 방법
TR201503136A2 (tr) * 2015-03-16 2016-09-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dronedaron ve esansiyel yağ asitlerinin farmasötik kompozisyonları.
US10851395B2 (en) 2016-06-10 2020-12-01 MARA Renewables Corporation Method of making lipids with improved cold flow properties
EP3559206B1 (en) 2016-12-22 2025-12-03 Mara Renewables Corporation Methods for producing biomass rich in dha, palmitic acid and protein using a eukaryotic microorganism
JP7101087B2 (ja) * 2018-09-05 2022-07-14 株式会社 伊藤園 軽度認知障害に対する緑茶成分の有効性評価方法
FR3092968B1 (fr) * 2019-02-22 2021-05-21 Microphyt Complement alimentaire
CN114555074A (zh) * 2019-08-08 2022-05-27 斯威本科技大学 长链多不饱和脂肪酸的用途
KR20220163979A (ko) 2020-04-03 2022-12-12 마라 리뉴어블즈 코퍼레이션 높은 수준의 오메가-3 지방산을 갖는 미생물 오일
DE102020115238A1 (de) * 2020-06-09 2021-12-09 Pm-International Ag Nahrungsergänzungsmittel und Nahrungsmittel
EP4176448A1 (en) * 2020-07-02 2023-05-10 Pear Therapeutics (US), Inc. Systems, methods, and devices for generating and administering digital therapeutic placebos and shams
CA3204546A1 (en) * 2021-01-15 2022-07-21 Cambridge Cognition Limited Methods and systems of identifying individuals for perioperative neurocognitive disorder and/or post-viral cognitive impairment
EP4637824A1 (en) * 2023-01-18 2025-10-29 Bioventures, Llc Method of preventing and treating alzheimer's disease and related dementias with drugs inhibiting the interaction between 14-3-3g protein and hexokinase-1 protein
JP2025079778A (ja) * 2023-11-10 2025-05-22 ダイドーグループホールディングス株式会社 生理機能改善用の組成物
WO2025100476A1 (ja) * 2023-11-10 2025-05-15 国立大学法人京都大学 生理機能改善用の組成物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
CA2164291C (en) * 1993-06-09 2007-10-30 David John Kyle Methods and pharmaceutical compositions useful for treating neurological disorders
US5928696A (en) 1994-08-16 1999-07-27 Dr. Frische Gmbh Process for extracting native products which are not water-soluble from native substance mixtures by centrifugal force
AU5346296A (en) * 1995-04-17 1996-11-07 Japan As Represented By Director-General Of Agency Of Industrial Science And Technology Novel microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fa tty acids by using the microorganisms
JP3985035B2 (ja) * 1995-09-14 2007-10-03 独立行政法人産業技術総合研究所 （ｎ−６）系ドコサペンタエン酸含有油脂ならびに該油脂の製造方法および用途
WO2000050547A1 (en) 1999-02-26 2000-08-31 Monsanto Company Process for separating a triglyceride comprising a docosahexaenoic acid residue from a mixture of triglycerides
AU2001232786A1 (en) 2000-01-11 2001-07-24 Monsanto Company Process for making an enriched mixture of polyunsaturated fatty acid esters
RU2336307C2 (ru) 2000-01-19 2008-10-20 Мартек Биосайнсис Корпорейшн Способ получения липидов (варианты) и липиды, полученные этим способом
EP1272048B1 (en) 2000-04-12 2008-05-21 Westfalia Separator GmbH Method for the fractionation of oil and polar lipid-containing native raw materials
CA2446059C (en) 2001-05-14 2010-03-23 Dsm Ip Assets B.V. Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
AU2002309856B2 (en) 2001-05-14 2008-10-23 Dsm Ip Assets B.V. Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
AU2002320251A1 (en) * 2001-07-05 2003-01-21 Vital Basics, Inc. Compositions for improving mental performance
WO2003092628A2 (en) 2002-05-03 2003-11-13 Martek Biosciences Corporation High-quality lipids and methods for producing by enzymatic liberation from biomass
US20090054523A1 (en) * 2005-01-24 2009-02-26 Morten Bryhn Use of a Fatty Acid Composition Containing DHA for the Production of a Medical Product or a Food Stuff for the Treatment of Amyloidos-Related Diseases
US8324276B2 (en) * 2005-01-24 2012-12-04 Pronova Biopharma Norge As Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
WO2006116755A2 (en) * 2005-04-28 2006-11-02 Trustees Of Tufts College Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function
EP1888081B1 (en) * 2005-05-23 2016-12-28 Massachusetts Institute of Technology Compositions containing pufa and methods of use thereof
BRPI0613358A8 (pt) * 2005-07-08 2017-12-26 Dsm Ip Assets Bv ácidos de gordura poli - insaturada para o tratamento da demência e condições relacionadas à pré-demência
WO2009002145A1 (en) * 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
JP2010532418A (ja) 2007-06-29 2010-10-07 マーテック バイオサイエンシーズ コーポレーション 多価不飽和脂肪酸のエステルの製造方法および精製方法
US20110177061A1 (en) * 2009-07-10 2011-07-21 Martek Biosciences Corporation Methods of treating and preventing neurological disorders using docosahexaenoic acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TREVOR A. MORI ET AL: "Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans", 《HYPERTENSION》 *

Also Published As

Publication number Publication date
EP2939671A1 (en) 2015-11-04
US20100203123A1 (en) 2010-08-12
EP2391361A1 (en) 2011-12-07
AU2016201382A1 (en) 2016-03-24
JP2020050675A (ja) 2020-04-02
CN104042600A (zh) 2014-09-17
CN108324706A (zh) 2018-07-27
JP2015143248A (ja) 2015-08-06
CA2751275A1 (en) 2010-08-05
US20130172412A1 (en) 2013-07-04
AU2010207929A1 (en) 2011-09-22
JP2012516852A (ja) 2012-07-26
HK1202243A1 (en) 2015-09-25
JP2018104477A (ja) 2018-07-05
JP2022059063A (ja) 2022-04-12
AU2017245327A1 (en) 2017-11-02
WO2010088700A1 (en) 2010-08-05

Similar Documents

Publication Publication Date Title
JP2022059063A (ja) 認知機能改善および心拍数低下のための方法
US11413263B2 (en) Reducing the risk of pathological effects of traumatic brain injury
US20100130608A1 (en) Compositions and methods for reducing triglyceride levels
JP6307442B2 (ja) 対象の高感度（ｈｓ−ｃｒｐ）のレベルを低下させる組成物および方法
ES2661217T3 (es) Composiciones y métodos para reducir los triglicéridos sin aumentar los niveles de LDL-C en un sujeto en terapia simultánea con estatinas
WO2011097273A1 (en) Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl lcystenine
US20130137767A1 (en) Methods and Compositions for Treating Arthritis with Docosahexaenoic Acid
US20110086914A1 (en) Methods for Treating Traumatic Brain Injury
US20110177061A1 (en) Methods of treating and preventing neurological disorders using docosahexaenoic acid
Bjørkkjær et al. Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil
AU2010207929B2 (en) Methods for improving cognitive function and decreasing heart rate
WO2011041710A2 (en) Docosahexaenoic acid gel caps
HK1172241A (en) Reducing the risk of pathological effects of traumatic brain injury
HK1172241B (en) Reducing the risk of pathological effects of traumatic brain injury

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: DISIMAN INTELLECTUAL PROPERTY ASSETS B.V.

Free format text: FORMER OWNER: MARTEK BIOSCIENCES CORP.

Effective date: 20130220

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20130220

Address after: Holland Heerlen

Applicant after: Disiman Intellectual Property Assets B.V.

Address before: American Maryland

Applicant before: Martek Biosciences Corp.

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120229